The therapeutic armamentarium for obstructive sleep apnea (OSA)-associated excessive daytime sleepiness (EDS) is limited, with few new therapies on the horizon. With just three therapies currently indicated for these patients, health care professionals (HCPs) are tasked with developing personalized and effective dosing and titration strategies for patients with OSA-associated EDS that consider patient behaviors, comorbidities, drug-drug interactions, and more—like in our patient, Alvin, who is stable and has had some improvement after 8 months on continuous positive airway pressure (CPAP) treatment but still has some difficulty with EDS.
Join us for this third of three BriefCase activities in which our expert faculty interweaves foundational knowledge with exercises for HCPs to practice new learnings with a case that emulates a patient with OSA and EDS seen in clinical practice.
Develop real-world dosing and titration strategies that personalize treatment for optimal outcomes in patients with EDS associated with OSA.
Supported by an educational grant from Axsome.
Sleep specialists, neurologists, psychiatrists, pulmonologists, primary care practitioners, nurse practitioners (NPs), physician associates (PAs), and pharmacists
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Malhotra reports the following financial relationships:
Consultant: Lilly; LivaNova; Jazz Pharmaceuticals, Inc.; and ZOLL Medical Corporation
Grants: National Institutes of Health (NIH)
Other financial or material support: ResMed (provided a philanthropic donation to UCSD
Disclosures were obtained from the following peer reviewer and CME Outfitters, LLC, staff, with no disclosures to report::
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at 877.CME.PROS (877.263.7767).